adenosine diphosphate has been researched along with Peripheral Arterial Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Criqui, MH; Ferrucci, L; Guralnik, JM; Kibbe, M; Kosmac, K; Leeuwenburgh, C; Li, L; McDermott, MM; Peek, CB; Polonsky, TS; Saini, SK; Sufit, RL; Tian, L | 1 |
| Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S; Steiner, S; Xhelili, E | 1 |
| Aalto, K; Hakovirta, H; Hollmén, M; Jalkanen, J; Jalkanen, S; Kiviniemi, T; Salomaa, V; Yegutkin, GG | 1 |
| Bounameaux, H; Cairols, MA; Clement, DL; Coccheri, S; Fiessinger, JN; Fletcher, JP; Hoffmann, U; Turpie, AG | 1 |
| Ballantyne, CM; Dong, JF; Kimball, KT; Lumsden, AB; Morrisett, JD; Nambi, V; Saunders, J; Virani, SS | 1 |
2 trial(s) available for adenosine diphosphate and Peripheral Arterial Diseases
| Article | Year |
|---|---|
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Pressure; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthalenes; Peripheral Arterial Disease; Placebos; Platelet Aggregation; Propionates; Thromboxanes; Time Factors | 2010 |
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arachidonic Acid; Aspirin; Azetidines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lower Extremity; Male; Middle Aged; Niacin; Peripheral Arterial Disease; Placebo Effect; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Stents; Time Factors; Treatment Outcome | 2011 |
3 other study(ies) available for adenosine diphosphate and Peripheral Arterial Diseases
| Article | Year |
|---|---|
Associations of Poly (ADP-Ribose) Polymerase1 abundance in calf skeletal muscle with walking performance in peripheral artery disease.
Topics: Adenosine Diphosphate; Aged; Humans; Muscle, Skeletal; Peripheral Arterial Disease; Poly Adenosine Diphosphate Ribose; Ribose; Walking | 2020 |
Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
Topics: Adenosine Diphosphate; Aged; Angioplasty; Angioplasty, Balloon, Coronary; Arachidonic Acid; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Monocytes; P-Selectin; Peptide Fragments; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Stents; Ticlopidine | 2014 |
Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Triphosphate; Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Angiotensin-Converting Enzyme Inhibitors; Antigens, CD; Apyrase; Artifacts; Atherosclerosis; Biomarkers; Chronic Disease; Comorbidity; Disease Progression; Drug Utilization; Female; Finland; GPI-Linked Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoxia; Male; Middle Aged; Models, Cardiovascular; Peripheral Arterial Disease; Purinergic P2Y Receptor Antagonists; Risk Factors; Second Messenger Systems; Smoking; Thrombophilia | 2015 |